Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Satsuma Pharmaceuticals, Inc. (STSA)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Satsuma Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Satsuma Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is STSA. The reporting company's CIK number is 1692830.
The total value of stock buying since 2005 is $44,999,985.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-09-17||Takanashi Ken (Director)||Buy||233,333||15.00||3,499,995|
|2019-09-17||Shah Rajeev M. (Director)||Buy||1,333,333||15.00||19,999,995|
|2019-09-17||Coulter James G||Buy||100,000||15.00||1,500,000|
Insider trading activities including stock purchases, stock sales, and option exercises of STSA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Satsuma Pharmaceuticals, Inc. (symbol STSA, CIK number 1692830) see the Securities and Exchange Commission (SEC) website.